Core Viewpoint - The company is planning to change its registered capital, abolish the supervisory board, and amend its Articles of Association in preparation for the 2025 first extraordinary general meeting of shareholders [2][5]. Group 1: Meeting Regulations - The board of directors is responsible for ensuring the protection of shareholders' legal rights and maintaining the order and efficiency of the meeting [2]. - Shareholders attending the meeting have the right to speak and vote, and must not disrupt the meeting's normal order [2][3]. - Voting will be conducted through a combination of on-site and online methods, with shareholders required to choose one method [3]. Group 2: Agenda and Proposals - The meeting will review two proposals, and there is no need for separate voting for small and medium investors [3]. - The first proposal involves changing the registered capital and abolishing the supervisory board, along with amending the Articles of Association [5]. - The company plans to distribute a cash dividend of 0.351 yuan per share and increase the share capital by 0.3 shares per share from capital reserves, changing the total share capital from 120 million shares to 156 million shares [5][8]. Group 3: Amendments to Governance - The supervisory board will be abolished, and its powers will be transferred to the audit committee of the board of directors [5]. - The amendments to the Articles of Association will comply with the latest regulations and reflect the company's operational realities [6]. - The company will no longer have a supervisory board, and the current supervisors will be relieved of their duties upon the approval of the proposal [5][6].
健尔康: 健尔康医疗科技股份有限公司2025年第一次临时股东大会会议资料